-
psnet.ahrq.gov/perspective/methicillin-resistant-staphylococcus-aureus
June 24, 2010 - These include health care workers, dialysis patients, patients with diabetes, injection drug users, patients … This may be due to initial antibiotic therapy that is not active against the infecting organism, resulting … in inappropriate treatment, serious underlying illness in the patient, or a combination of both. … January 19, 2011
WebM&M Cases
Delayed Diagnosis and Treatment
-
www.ahrq.gov/patient-safety/settings/long-term-care/resource/facilities/ltc/gdmodap3b.html
October 01, 2014 - An individual's condition and treatment can directly impact his/her fall risk. … An individual's condition and treatment can directly impact his/her fall risk.
-
www.ahrq.gov/sites/default/files/wysiwyg/ncepcr/tools/PCMH/pcpf-module-32-self-management-support.pdf
September 01, 2015 - activities and tasks
that patients engage in to live with chronic illness
including managing symptoms, treatment … Patients’ adherence to treatment recommendations can be affected by inaccurate information and
myths … in the patient community about treatments such as insulin, which sometimes results in
amputations and … OnlyOneforMiles is interested in working with you to implement panel
management and to improve their diabetes
-
www.ahrq.gov/hai/cusp/modules/implement/teamwork.html
December 01, 2012 - Communication Breakdowns Cause Treatment Delays
Slide 7. … Communication Breakdowns Cause Treatment Delays 3
Root Causes of Treatment Delays (1995-2004)
The … root causes of treatment delays are as follows:
Communication 86%
Patient Assessment 77%
Continuum
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/registry-of-patient-registries_research.pdf
April 15, 2019 - ,
procedures, interventions, or therapies. … recommended data elements for 18 domains (e.g.,
demographics, adverse events) that are common to most therapeutic … Data Strategy (Diabe-DS) Data harmonization Created common data elements for Type 1 diabetes using a … the process by which
characteristics determine treatment, and characteristics and treatment together … ,
which are considered surrogate outcomes of cardiovascular health or the health of patients with
diabetes
-
hcup-us.ahrq.gov/reports/statbriefs/sb146.pdf
March 01, 2012 - of devices $4.0 $5.1 $10,100 $12,500 2.0%
Biliary tract disease $3.5 $5.0 $7,700 $10,600 2.7%
Diabetes … adjustment of devices (2.0%)
Chronic obstructive pulmonary
disease and bronchiectasis (3.1%)
Diabetes … DRGs group patients according to diagnosis,
type of treatment (procedures), age, and other relevant … However, if a patient received long-term care, rehabilitation, or treatment for psychiatric or
chemical
-
www.uspreventiveservicestaskforce.org/uspstf/document/cost-effectiveness-analyses-of-population-based-screening-for-abdominal-aortic-aneurysm-evidence-synthesis/abdominal-aortic-aneurysm-screening-february-2005
February 15, 2005 - How will differences in treatment effectiveness affect cost-effectiveness estimates for AAA screening … and quality-of-life estimates were included for renal failure, stroke, major amputation (related to diabetes … Downstream costs post-treatment were included. … How will differences in treatment effectiveness affect cost-effectiveness estimates for AAA screening … None considered patient-incurred burdens of time and money related to AAA screening and treatment.
-
www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/mrsa-2/029-ss-review-ssi-prevention-fg.docx
April 01, 2025 - Key questions are asked for each patient, such as:
· How many days did the patient complete home treatment … Jones was a 64-year-old male with a history of arthritis, diabetes, and a year-long history of back pain … Conservative treatments (physical therapy and steroid injections) were not effective, and Mr. … the Nasal Decolonization section, the checklist indicates that he completed only 3 days of mupirocin treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-pancreas_research-protocol.pdf
August 09, 2013 - percent.5
Risk factors for pancreatic cancer include tobacco use; a personal history of pancreatitis,
diabetes … between these populations
and burden of disease may be related to higher rates of cigarette smoking and diabetes … that some Stage III cases are borderline resectable and may be appropriate targets
for neoadjuvant therapy … adenocarcinoma is fatal if untreated, so it is critical to choose the right imaging
test and initiate therapy … Were the study results unaffected by intervening treatments or disease
progression/regression?
-
www.ahrq.gov/sites/default/files/wysiwyg/ncepcr/tools/PCMH/pcpf-module-26-ehr-and-mu.pdf
September 01, 2015 - can organize data on vital signs,
smoking status, immunizations, referrals, laboratory tests, drug therapy … , and diabetes self-
management. … CDS Starter Kit: Diabetes follow-up care. … CDS Starter Kit: Diabetes follow-up care. … CDS Starter Kit: Diabetes follow-up care.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholders-engagement-others_white-paper.pdf
September 01, 2013 - contributed clinical data to provide information on “real world” practice and the effectiveness of
treatments … registries currently exist for a wide range of
chronic or rare conditions, including many forms of cancer, diabetes … recruit patients for clinical trials to learn about a particular
disease or condition; to develop therapeutics … PPRs have also added to disease and treatment knowledge. … • Research across conditions/concomitant treatments.
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017308-samore-final-report-2011.pdf
January 01, 2011 - 1.18,3.68
Chronic obstructive pulmonary disease 1.15 0.40,3.27
Congestive heart failure 1.06 0.48,2.35
Diabetes … Shared decision making
between patients and physicians is considered optimal for determining treatments … Shared decision making results in appropriate treatments for
patient needs -determined by patient disclosure … Treatments resulting from shared decision making can be incorporated successfully into patient’s
lives … In addition, patients reported their
preference for how decisions regarding treatments are made.
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-145-fullreport.pdf
July 01, 2016 - treatment or behavior therapy—and with consistent follow-
up, the likelihood of continuation and adherence … • Behavior Therapy as First-Line Treatment for Preschool-Aged Children, which measures the
percentage … dimensions including: accurate diagnosis with a
validated tool, eligible age for diagnosis, behavior therapy … are participating in a chronic care model have been found to
be more knowledgeable, use recommended therapies … The cost-effectiveness of improving diabetes care in U.S.
-
hcup-us.ahrq.gov/reports/methods/2020-04.pdf
January 01, 2020 - services, medical practice patterns, patient safety, access to health care programs,
and outcomes of treatments … and over
a Based on four AHRQ PQIs for short-term diabetes complications, long-
term diabetes complications … , uncontrolled diabetes, and lower-extremity
amputation among patients with diabetes. … , init
'T4142XA' Poisoning by unsp anesthetic, intentional self-harm, init
'T415X2A' Poisoning by therapeutic … P0449' Newborn affected by maternal use of other drugs of addiction
'P962' Withdrawal symptoms from therapeutic
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2012_MaskedStats_Core_V2.PDF
January 01, 2012 - PROC W/O CC/MCC 625 0.00%
637: DIABETES W MCC 21,073 0.16%
638: DIABETES W CC 71,929 0.53%
639: DIABETES … W MCC 10,184 0.08%
920: COMPLICATIONS OF TREATMENT W CC 16,306 0.12%
921: COMPLICATIONS OF TREATMENT … mellitus without complication 6,776 0.05%
50: Diabetes mellitus with complications 215,944 1.60%
51 … 15,492 0.12%
146: Treatment; fracture or dislocation of hip and femur 55,391 0.41%
147: Treatment; … radiology for cancer treatment 14,810 0.11%
212: Diagnostic physical therapy 6,118 0.05%
213: Physical
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2010_MaskedStats_Core_V2.PDF
January 01, 2010 - PROC W/O CC/MCC 695 0.00%
637: DIABETES W MCC 29,874 0.21%
638: DIABETES W CC 61,181 0.44%
639: DIABETES … W MCC 9,802 0.07%
920: COMPLICATIONS OF TREATMENT W CC 14,995 0.11%
921: COMPLICATIONS OF TREATMENT … mellitus without complication 8,529 0.06%
50: Diabetes mellitus with complications 218,634 1.57%
51 … 17,667 0.13%
146: Treatment; fracture or dislocation of hip and femur 56,243 0.40%
147: Treatment; … radiology for cancer treatment 17,764 0.13%
212: Diagnostic physical therapy 6,463 0.05%
213: Physical
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2011_MaskedStats_Core_V2.PDF
January 01, 2011 - PROC W/O CC/MCC 728 0.01%
637: DIABETES W MCC 20,958 0.15%
638: DIABETES W CC 73,106 0.53%
639: DIABETES … W MCC 9,789 0.07%
920: COMPLICATIONS OF TREATMENT W CC 16,646 0.12%
921: COMPLICATIONS OF TREATMENT … mellitus without complication 8,242 0.06%
50: Diabetes mellitus with complications 222,901 1.60%
51 … 17,116 0.12%
146: Treatment; fracture or dislocation of hip and femur 56,330 0.40%
147: Treatment; … radiology for cancer treatment 16,766 0.12%
212: Diagnostic physical therapy 6,144 0.04%
213: Physical
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2011_MaskedStats_Core_V2_Weighted.PDF
January 01, 2011 - PROC W/O CC/MCC 1,726 0.00%
637: DIABETES W MCC 49,205 0.13%
638: DIABETES W CC 175,273 0.47%
639: … DIABETES W/O CC/MCC 138,840 0.38%
640: MISC DISORDERS OF NUTRITION,METABOLISM,FLUIDS/ELECTROLYTES W … W MCC 23,913 0.06%
920: COMPLICATIONS OF TREATMENT W CC 41,634 0.11%
921: COMPLICATIONS OF TREATMENT … 43,298 0.12%
146: Treatment; fracture or dislocation of hip and femur 143,699 0.39%
147: Treatment … radiology for cancer treatment 41,260 0.11%
212: Diagnostic physical therapy 12,984 0.04%
213: Physical
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2013_MaskedStats_Core.PDF
January 01, 2013 - PROC W/O CC/MCC 667 0.00%
637: DIABETES W MCC 24,566 0.17%
638: DIABETES W CC 78,738 0.55%
639: DIABETES … W MCC 11,453 0.08%
920: COMPLICATIONS OF TREATMENT W CC 17,350 0.12%
921: COMPLICATIONS OF TREATMENT … lower GI therapeutic procedures 35,847 0.25%
96: Other OR lower GI therapeutic procedures 42,861 0.30% … 14,456 0.10%
146: Treatment; fracture or dislocation of hip and femur 64,310 0.45%
147: Treatment; … radiology for cancer treatment 14,911 0.10%
212: Diagnostic physical therapy 6,762 0.05%
213: Physical
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2012_MaskedStats_Core_V2_Weighted.PDF
January 01, 2012 - PROC W/O CC/MCC 1,556 0.00%
637: DIABETES W MCC 51,187 0.14%
638: DIABETES W CC 177,546 0.49%
639: … DIABETES W/O CC/MCC 130,103 0.36%
640: MISC DISORDERS OF NUTRITION,METABOLISM,FLUIDS/ELECTROLYTES W … W MCC 25,722 0.07%
920: COMPLICATIONS OF TREATMENT W CC 41,565 0.11%
921: COMPLICATIONS OF TREATMENT … 40,159 0.11%
146: Treatment; fracture or dislocation of hip and femur 144,268 0.40%
147: Treatment … radiology for cancer treatment 38,622 0.11%
212: Diagnostic physical therapy 12,816 0.04%
213: Physical